Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …
Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention
Z Khatoon, CD McTiernan, EJ Suuronen, TF Mah… - Heliyon, 2018 - cell.com
In living organisms, biofilms are defined as complex communities of bacteria residing within
an exopolysaccharide matrix that adheres to a surface. In the clinic, they are typically the …
an exopolysaccharide matrix that adheres to a surface. In the clinic, they are typically the …
Inhaled amikacin to prevent ventilator-associated pneumonia
S Ehrmann, F Barbier, J Demiselle… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether preventive inhaled antibiotics may reduce the incidence of ventilator-
associated pneumonia is unclear. Methods In this investigator-initiated, multicenter, double …
associated pneumonia is unclear. Methods In this investigator-initiated, multicenter, double …
Antibiotic resistance in Pseudomonas aeruginosa–Mechanisms, epidemiology and evolution
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …
Bloodstream infections in critically ill patients: an expert statement
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …
signs of infection and may be either secondary to a documented source or primary—that is …
Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
Pseudomonas aeruginosa, a Gram-negative bacterium, is recognized for its adaptability and
opportunistic nature. It poses a substantial challenge in clinical settings due to its …
opportunistic nature. It poses a substantial challenge in clinical settings due to its …
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) …
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) …
[CARTE][B] Global report on infection prevention and control
World Health Organization - 2022 - books.google.com
Page 1 + Clinical care Water, sanitation and hygiene Outbreak preparedness and response
Health system strengthening International health regulations Patient safety Quality …
Health system strengthening International health regulations Patient safety Quality …
Rationalizing antimicrobial therapy in the ICU: a narrative review
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …
The impact of healthcare-associated infections on mortality in ICU: A prospective study in Asia, Africa, Eastern Europe, Latin America, and the Middle East
Background The International Nosocomial Infection Control Consortium has found a high
ICU mortality rate. Our aim was to identify all-cause mortality risk factors in ICU-patients …
ICU mortality rate. Our aim was to identify all-cause mortality risk factors in ICU-patients …